Topic: Pharmaceuticals Sector
LONDON (Reuters) - Drugmakers are counting the cost of the deepening euro zone crisis, with further austerity-driven price cuts expected in important European markets, including Italy and France.Growing alarm at multiple government-imposed cuts prompted a frank letter from the CEO of GlaxoSmithKline, ...
(Reuters) - The Food and Drug Administration has declined to approve an oral contraceptive and a glaucoma treatment being developed by Merck & Co Inc, but the drugmaker did not disclose details of the agency's concerns.Merck already sells both products in some ...
China has sentenced to death the former president of state-owned Shanghai Pharmaceutical Group for corruption, state media said Wednesday, in a case that has fuelled concerns over drug safety.A Shanghai court on Tuesday sentenced Wu Jianwen, 42, to death with a two-year ...
ZURICH (Reuters) - Novartis' Ilaris helps patients with the most serious form of childhood arthritis, a second late-stage study has shown, further boosting prospects for the Swiss drugmaker's medicine that hit a setback earlier this year.Ilaris, or ACZ885, met both of its ...
(Reuters) - Novartis's recently acquired eyecare business Alcon is facing a U.S. government investigation into alleged healthcare fraud, the Swiss drugmaker said on Tuesday.Alcon received a subpoena from the U.S. Department of Health and Human Services on September 23 requesting the production ...
Swiss pharmaceutical giant Novartis said on Tuesday it would slash 2,000 jobs, mostly in Switzerland and the United States, despite reporting third quarter net profits of $3.53 billion (2.5 billion euros).The firm said in a statement that profits for the quarter were ...
ZURICH (Reuters) - Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday.The Basel-based group has already ...
(Reuters) - Forest Laboratories Inc is looking more at earlier-stage products to acquire rather than more advanced ones because it feels confident it can weather the patent expirations of its two biggest medicines, the drugmaker's finance chief said on Thursday.Forest has one ...
LONDON (Reuters) - Europe will strictly limit the amount of information that drugmakers can supply to the public on prescription-only medicines and retain a ban on advertising under proposed rules set out on Tuesday.The latest proposals from the European Commission amend those ...
(Reuters) - AstraZeneca Plc said on Thursday it will cut about 400 jobs from its U.S. commercial business as Britain's second-largest drugmaker seeks to reduce costs.The cuts will hit the company's U.S. headquarters in Wilmington, Delaware, as well as some field-based, non-sales ...
Photo Gallery
-
Art Auction
This photograph provided by Farnsworth Art Museum show the 1969 painting "Portrait ...AP News - -
Pfizer CEO Resigns
FILE - In this Jan. 26, 2009 file photo, Jeffrey Kindler, chairman and ...AP News - -
Eli Lilly Acquisition
FILE - In this Jan. 25, 2006 file photo, the Eli Lilly and ...AP News -
From Around the Web
Video Gallery
-
Indian pharma sector to grow in ...
Kiran Mazumdar Shaw, CMD, Biocon told NDTV Profit that they ...2012-01-09 -
Doing Business with India's Pharmaceutical ...
(www.abndigital.com) India is one of the fastest-growing pharmaceutical ...2011-11-30 -
Pharmaceuticals Industry In India
India is the world's 3rd largest pharmaceutical producer, Cardiovascular ...2011-12-10
